DA

Daniel L. Alkon

BI Blanchette Rockefeller Neurosciences Institute: 20 patents #1 of 8Top 15%
CE Cognitive Research Enterprises: 8 patents #1 of 5Top 20%
US US Dept of Health & Human Services: 8 patents #80 of 3,044Top 3%
SY Synaptogenix: 6 patents #1 of 2Top 50%
EI Environmental Research Institute: 4 patents #8 of 80Top 10%
WU West Virginia University: 4 patents #17 of 238Top 8%
EI Erim International: 2 patents #3 of 15Top 20%
TA The United States Of America: 2 patents #21 of 521Top 5%
📍 Chevy Chase Section Five, MD: #5 of 42 inventorsTop 15%
🗺 Maryland: #169 of 35,612 inventorsTop 1%
Overall (All Time): #41,492 of 4,157,543Top 1%
58
Patents All Time

Issued Patents All Time

Showing 1–25 of 58 patents

Patent #TitleCo-InventorsDate
12405268 Lymphocyte-based morphometric test for alzheimer's disease Florin Valentin Chirila 2025-09-02
12016837 Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases Thomas J. Nelson 2024-06-25
11826345 Dosing regimens of PKC activators 2023-11-28
11820745 PKC-activating compounds for the treatment of neurodegenerative diseases Thomas J. Nelson 2023-11-21
11415574 Lymphocyte-based morphometric test for alzheimer's disease Florin Valentin Chirila 2022-08-16
11390596 PKC-activating compounds for the treatment of neurodegenerative diseases Thomas J. Nelson 2022-07-19
11273139 Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases Thomas J. Nelson 2022-03-15
11173140 Dosing regimens of PKC activators 2021-11-16
11099174 Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communication Florin Valentin Chirila, Tapan Kumar Khan 2021-08-24
11045447 Methods for inducing synaptogenesis with synaptic growth factor activating compounds 2021-06-29
10821079 PKC activators and combinations thereof Thomas J. Nelson 2020-11-03
10696644 PKC-activating compounds for the treatment of neurodegenerative diseases Thomas J. Nelson 2020-06-30
10323011 PKC-activating compounds for the treatment of neurodegenerative diseases Thomas J. Nelson 2019-06-18
10317396 Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communication Florin Valentin Chirila, Tapan Kumar Khan 2019-06-11
10137106 Compositions and methods to treat niemann-pick disease 2018-11-27
10010584 Treatment of depressive disorders Miao Sun 2018-07-03
9974832 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury Ofer Zohar 2018-05-22
9962357 Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases Thomas J. Nelson 2018-05-08
9889183 PKC activators and anticoagulant in regimen for treating stroke 2018-02-13
9833435 Compositions and methods to treat Niemann-Pick disease 2017-12-05
9797913 Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB) Tapan Kumar Khan 2017-10-24
9597312 Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators Miao Sun 2017-03-21
9539235 Methods for Alzheimer's disease treatment and cognitive enhancement Rene Etcheberrigaray 2017-01-10
9446020 Methods for Alzheimer'S disease treatment and cognitive enhancement Rene Etcheberrigaray 2016-09-20
9345685 Methods for Alzheimer's Disease treatment and cognitive enhancement 2016-05-24